GSK
LIVE

Serial Number

97446090

Owner

SmithKline Beecham Limited

Attorney

Christopher M. Hanes

Filing Date

Jun 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GSK Trademark

Serial Number: 97446090

GSK is a trademark filed by SmithKline Beecham Limited on June 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

SmithKline Beecham Limited

980 Great West Road
Brentford, Middlesex TW89GS

Entity Type: 99

Trademark Details

Filing Date

June 7, 2022

Registration Date

Not Registered

Published for Opposition

August 1, 2023

Goods & Services

Scientific research for medical purposes in the field of pharmaceuticals, vaccines, cell and gene therapy; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting genetic testing for research purposes; scientific research consulting; medical laboratory services; Providing medical and scientific research information; computer system design services in the nature of design of computational models and systems of artificial intelligence; medical and pharmacological research services; software development, programming and implementation; research in the field of gene and cell therapy; provision of information, consultancy and advisory services relating to any of the aforesaid services

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; adjuvants for medical purposes; medicated and sanitizing soaps and detergents

Downloadable computer software for use in enabling healthcare professionals to access information on pharmaceutical and medical related products and services; downloadable computer software programs using artificial intelligence for use in machine learning

Educational services, namely, conducting classes in the field of pharmaceutical, diagnostic, vaccines, proprietary medicines, health, medical and skin care industries; educational services, namely, conducting seminars regarding health and health awareness and distributing course material in connection therewith; academic education, instruction and training, namely, conducting classes in the field of science, biotechnology, biology, health, health awareness and life sciences; conducting, organizing and arranging conferences, seminars and exhibitions for educational purposes in the field of medicine, health and wellness; publication of documents recorded on electronic storage media and on the internet in the field of scientific, medical diagnostic and technical laboratory matters and for research; training in the operation, repair and maintenance of scientific, surgical and medical devices and apparatus; publishing and issuing of scientific papers in the field of pharmaceuticals, diagnostic, vaccines, proprietary medicines, health, medical and skin care; provision of information, consultancy and advisory services relating to any of the aforesaid services

Advertising, marketing and promotional services; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; the provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical, healthcare and fitness products through an on-line computer network; retail and wholesale store services featuring pharmaceuticals; distribution of advertising, marketing and promotional material

Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; gene and cell therapy medical treatment services; genetic testing for medical purposes; provision of information, consultancy and advisory services relating to any of the aforesaid services

Surgical apparatus and instruments for medical use; medical fluid injectors; medical apparatus and instruments for use in the diagnosis and treatment of skin diseases, conditions and disorders; transcutaneous electrical nerve stimulation devices to treat body pain; implantable electrodes for medical purposes; adaptive open and or closed-loop bioelectronic medical devices that deliver stimulation and/or blocking to a nerve and optionally can record incoming action potentials and physiological parameters, analyze data in real time and modulate neural signaling; drug delivery devices sold empty, namely, syringes for medical purposes and for injections; surgical implants comprising artificial material

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2026 EXRA
SOU EXTENSION 4 GRANTED
Mar 6, 2026 EX4G
SOU EXTENSION 4 FILED
Mar 6, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 6, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2025 EXRA
SOU EXTENSION 3 GRANTED
Sep 10, 2025 EX3G
SOU EXTENSION 3 FILED
Sep 10, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 12, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 12, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 12, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 23, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 23, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 23, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 11, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 11, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 11, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 19, 2024 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 8, 2024 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 18, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 1, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 1, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 12, 2023 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jun 29, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 23, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 2, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 2, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 2, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2022 REAP
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 16, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 15, 2022 NWOS
NEW APPLICATION ENTERED
Jun 10, 2022 NWAP